Navigation Links
Drugs May Help Healthy Men Lower Prostate Cancer Risk
Date:2/24/2009

New guidelines suggest that men discuss use of medicines such as Propecia with their doctor

TUESDAY, Feb. 24 (HealthDay News) -- Healthy men with no signs of prostate cancer may wish to talk to their doctors about taking a drug that could further reduce their risk for the disease, new guidelines suggest.

The American Society of Clinical Oncology and the American Urological Association have issued new guidelines recommending that these men talk to their doctors about using a 5-alpha reductase inhibitors (5-ARI). These drugs -- which include finasteride (Propecia), used to treat male pattern baldness -- can reduce levels of dihydrotestosterone (DHT), a hormone that spurs prostate cancer development.

Previous studies have been shown that 5-ARIs reduce risk of contracting the illness by 25 percent.

Prostate cancer is the second-leading cause of death by cancer in men.

"Although one in every six men in the United States will be diagnosed with prostate cancer, we are not recommending that all men take 5-ARIs," co-chair of the guideline panel Dr. Barnett S. Kramer, associate director for disease prevention at the National Institutes of Health, stressed in a news release issued by the organizations. "However, we would encourage men to begin a dialogue with their doctors to determine if they could benefit from taking 5-ARIs to reduce their prostate cancer risk."

The guidelines call for doctors to discuss the pro and cons of a 5-ARI with male patients who score a 3.0 or lower on a prostate-specific antigen (PSA) test, show no signs of prostate cancer, and receive (or plan to receive) regular disease screening.

The guidelines also suggest that men already taking a 5-ARI for other conditions should discuss continuing the medication as a way to prevent prostate cancer. Today, 5-ARIs are used to treat male-pattern baldness and benign prostatic hyperplasia (enlarged prostate) among other non-cancerous conditions.

While supporting the guidelines, panel co-chair Dr. Paul F. Schellhammer noted that while 5-ARIs may decrease the risk of getting prostate cancer, it is not known whether these drugs reduce death from the disease.

"However, the demonstrated effect of 5-ARIs in reducing prostate cancer incidence makes it reasonable to recommend them for use to prevent the disease," he said in the same news release.

The guidelines are scheduled to appear in the March issue of the Journal of Clinical Oncology and The Journal of Urology.

More information

The U.S. National Cancer Institute has more about prostate cancer.



-- Kevin McKeever



SOURCE: American Society of Clinical Oncology/American Urological Association, news release, Feb. 24, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Finding May Lead to New Drugs for Urinary Infections
2. Rheumatoid Arthritis Drugs Raise Shingles Risk
3. Asthma drugs need to be maintained for continued benefit
4. Doctors Guide to Cancer Drugs May Need Revising
5. Patient Savings on Prescription Drugs Reach Record High for 2008, Goal Announced for 2009
6. New guidelines for prescribing opioid pain drugs published
7. New Guidelines for Prescribing Opioid Pain Drugs Published
8. New guideline for prescribing opioid pain drugs published
9. Fertility Drugs Do Not Increase Ovarian Cancer Risk
10. drugstore.com inc. Reports Profitable Fourth Quarter of 2008 and Free Cash Flow of $5.4 Million on Record OTC Sales
11. Drugs from Biogen Idec and Merck are the Most Promising Therapies in Development in the Acute Heart Failure Market
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drugs May Help Healthy Men Lower Prostate Cancer Risk
(Date:1/20/2017)... , ... January 20, 2017 , ... “The Angel”: ... Lord has set out for each of his children. “The Angel” is the creation ... of Music in New York City, and impassioned writer. , When asked of her ...
(Date:1/20/2017)... ... ... beautiful and enchanting tale that teaches children the true meaning of Christmas. “Journey to Christmas” ... and a devoted woman of faith. , “Becoming a parent changes you. In my ... mind for years, but actually doing it might have been a while in coming if ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... On-demand E-learning system for Clinical and Regulatory education for Physicians, Physician Advisors, ... Aerolib`s successful education methodology of Disease Specific Documentation Improvement. , The Aerolib ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... for tech innovators, engineers, and scientists from around the world, announces the launch ... users a quick and easy portal to research breakthroughs and trending news, vital ...
(Date:1/19/2017)... ... January 19, 2017 , ... Catalent Pharma Solutions, the ... and consumer health products, today announced that it will be co-hosting a workshop ... excipients and drug delivery solutions to health industries worldwide. The one day event ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
(Date:1/19/2017)... The global  pacemaker market  is expected to reach USD 12.3 billion by ... prevalence of cardiac conditions coupled with the availability of medical coverage is a ... in these devices are supporting the expansion of this vertical. ... ... View Research Logo ...
(Date:1/19/2017)... 18, 2017 The Global Therapy Partnering Terms ... to partnering deals and agreements entered into by the ... deals - Top deals by value - Deals listed ... type The report provides understanding and access to ... world,s leading healthcare companies. The report provides an ...
Breaking Medicine Technology: